Inventor
PROBST JOCHEN
DE37 patents
⚠️ This page may combine multiple inventors who share the name “PROBST JOCHEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CUREVAC AG
22 patentsUS10912826B2Feb 9, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG45 citations98
US10799577B2Oct 13, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG28 citations98
US10682406B2Jun 16, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG29 citations98
US10434158B2Oct 8, 2019
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG31 citations98
US10166283B2Jan 1, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC AG37 citations98
US10117920B2Nov 6, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US10111968B2Oct 30, 2018
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG39 citations98
US9974845B2May 22, 2018
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG32 citations98
US9839697B2Dec 12, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG39 citations98
US10918740B2Feb 16, 2021
RNA containing composition for treatment of tumor diseases
CUREVAC AG38 citations97
US10293058B2May 21, 2019
RNA containing composition for treatment of tumor diseases
CUREVAC AG50 citations97
US11458195B2Oct 4, 2022
Combination of vaccination and inhibition of the PD-1 pathway
CUREVAC AG12 citations94
US11110156B2Sep 7, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
CUREVAC AG28 citations94
US10898589B2Jan 26, 2021
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10653799B2May 19, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CUREVAC AG28 citations94
US10610605B2Apr 7, 2020
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC AG28 citations94
US10232024B2Mar 19, 2019
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded allergenic antigen or an autoimmune self-antigen
CUREVAC AG32 citations94
US10010592B2Jul 3, 2018
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
CUREVAC AG36 citations94
US10869935B2Dec 22, 2020
RNA containing composition for treatment of tumor diseases
CUREVAC AG29 citations93
US10434154B2Oct 8, 2019
Composition for treating prostate cancer (PCa)
CUREVAC AG29 citations93
US10017826B2Jul 10, 2018
Method for producing RNA
CUREVAC AG29 citations93
US9402887B2Aug 2, 2016
Composition for treating prostate cancer (PCa)
CUREVAC AG30 citations93
CureVac SE
5 patentsUS11559570B2Jan 24, 2023
Prime-boost regimens involving administration of at least one mRNA construct
CureVac SE8 citations86
US12109275B2Oct 8, 2024
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
CureVac SE1 citations73
US12201680B2Jan 21, 2025
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CureVac SE0 citations63
US12447209B2Oct 21, 2025
Combination of vaccination and inhibition of the PD-1 pathway
CureVac SE0 citations62
US12048738B2Jul 30, 2024
Composition for treating prostate cancer (PCa)
CureVac SE0 citations61
CUREVAC GMBH
3 patentsUS9669089B2Jun 6, 2017
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
CUREVAC GMBH107 citations99
US9447431B2Sep 20, 2016
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
CUREVAC GMBH70 citations98
US9352028B2May 31, 2016
Composition for treating lung cancer, particularly of non-small lung cancers (NSCLC)
CUREVAC GMBH33 citations90